Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
C2185

Pharmacist Failed to Identify and Report Medication Order Irregularity

Redding, California Survey Completed on 10-22-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility's consultant pharmacist (CP) failed to identify and report an irregularity in a physician's order for cyclobenzaprine, a muscle relaxant, for a resident who was admitted with a left hip replacement and chronic pulmonary edema. The physician's order specified cyclobenzaprine 5 mg by mouth every eight hours as needed for pain and muscle spasms in both legs, but the medication administration record (MAR) did not document the specific indication—whether it was given for pain or muscle spasms—each time the medication was administered. The facility's policy required the CP to review medication orders monthly and report any irregularities, including medications without adequate monitoring, to the physician for review. During the monthly medication regimen review, the CP did not identify or report the lack of documentation regarding the indication for cyclobenzaprine administration. In an interview, the CP acknowledged that there was no documentation indicating the reason for each administration of cyclobenzaprine and admitted this was a missed opportunity to catch the irregularity during the review. The deficiency was identified for one resident, and no irregularities were reported for cyclobenzaprine prior to the resident's discharge.

An unhandled error has occurred. Reload 🗙